Impact of vaccination with Cervarix™ on subsequent HPV-16/18 infection and cervical disease in women 15–25 years of age

Sustained efficacy up to 4·5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

2006 • 1,766 citations

Human papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: A meta‐analysis update

2007 • 1,654 citations

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial

2004 • 1,624 citations

Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial

2007 • 1,287 citations

Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis

2006 • 1,101 citations

The Elevated 10-Year Risk of Cervical Precancer and Cancer in Women With Human Papillomavirus (HPV) Type 16 or 18 and the Possible Utility of Type-Specific HPV Testing in Clinical Practice

2005 • 1,038 citations

Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study

2001 • 814 citations

Relation of human papilloma virus status to cervical lesions and consequences for cervical-cancer screening: a prospective study

1999 • 700 citations

The Rising Incidence of Adenocarcinoma Relative to Squamous Cell Carcinoma of the Uterine Cervix in the United States—A 24-Year Population-Based Study

2000 • 691 citations

Worldwide Human Papillomavirus Etiology of Cervical Adenocarcinoma and Its Cofactors: Implications for Screening and Prevention

2006 • 656 citations

Persistent Human Papillomavirus Infection as a Predictor of Cervical Intraepithelial Neoplasia

2001 • 590 citations

The carcinogenicity of human papillomavirus types reflects viral evolution

2005 • 552 citations

Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases

2006 • 552 citations

Projected Clinical Benefits and Cost-effectiveness of a Human Papillomavirus 16/18 Vaccine

2004 • 541 citations

Type-Specific Persistence of Human Papillomavirus DNA before the Development of Invasive Cervical Cancer

1999 • 495 citations

Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study

2002 • 423 citations

Persistence and load of high‐risk HPV are predictors for development of high‐grade cervical lesions: A longitudinal French cohort study

2003 • 416 citations

Development and Duration of Human Papillomavirus Lesions, after Initial Infection

2005 • 403 citations

International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas

1998 • 314 citations

International trends in incidence of cervical cancer: II. Squamous-cell carcinoma

2000 • 283 citations

Efficacy of a Bivalent L1 Virus-Like Particle Vaccine in Prevention of Infection With Human Papillomavirus Types 16 and 18 in Young Women: A Randomized Trial

2005 • 259 citations

Detection of Human Papillomavirus DNA in Cytologically Normal Women and Subsequent Cervical Squamous Intraepithelial Lesions

1999 • 252 citations

Efficacy and other milestones for human papillomavirus vaccine introduction

2004 • 214 citations

Findings to date from the ASCUS-LSIL Triage Study (ALTS).

2003 • 214 citations

Findings to Date From the ASCUS-LSIL Triage Study (ALTS)

2003 • 213 citations

A prospective study showing long-term infection with human papillomavirus 16 before the development of cervical carcinoma in situ.

2000 • 136 citations

Cervical cancer in the Netherlands 1989-1998: Decrease of squamous cell carcinoma in older women, increase of adenocarcinoma in younger women

2004 • 133 citations

Role of human papillomavirus in the carcinogenesis of squamous cell carcinoma and adenocarcinoma of the cervix

2005 • 118 citations

Strategies for the introduction of human papillomavirus vaccination: modelling the optimum age- and sex-specific pattern of vaccination in Finland

2007 • 86 citations

Substantial impact on precancerous lesions and HPV infections through 5.5 years in women vaccinated with the HPV-16/18 L1 VLP AS04 candidate vaccine

2007 • 37 citations

Factors predicting disease outcome in early stage adenocarcinoma of the uterine cervix

2002 • 16 citations

Expression of Ki-67 and squamous intraepithelial lesions are related with HPV in endocervical adenocarcinoma

2005 • 13 citations

Distribution of Epithelial-Specific Antigen in Uterine Cervix with Endocervical Glandular Dysplasia

1997 • 6 citations

Deleted Work

1955 • 0 citations

Cited By (0)

No citing papers found in database